“…In spirocyclic oxindole-based MDM2 inhibitors, the oxindole fragment occupies the Trp23-containing cleft of P53, and appropriate stereochemistry is critical for good binding affinity 73 , 74 . Therefore, we focused on asymmetric synthesis of optically pure C3-spirooxindoles 75 , 76 , 77 , 78 . We started from hydronaphthalene 79 , 80 , 81 , 82 , 83 , 84 and spirooxindole 10 , 22 , 23 , 25 , 65 because they are privileged frameworks occurring in many anti-tumor natural products and pharmaceuticals.…”